let’s not let facts get in the way of a good story toxic futures (OEL only hedged through to September 22 - BYE hedges in place through to the end of the year ….). Hardly toxic in the schemes of things.
Not sure I would gloat about bye A team success in the past 24 months they have drilled a number of sub par wells only G#1 looks like it will repay itself and doesn’t look like it will do much more E2 is early on but we don’t know what it cost nor the decline G#2 and F#4 look like they will not recover a fraction of the drilling and completion costs.
BYE total production from SM58 G1 and G2 and Sm69 E2 (call it ~USD$60m of expenditure across the platform/well cost and completions) of 1000bopd and 7 Mcfetridge does not even combine to what the company expected from the G1 well alone being 1000bopd & 20mmcf.
maynards infamous of anything less than >$1 SP writhing 18 months call of 24 months ago has not aged well for those who care to remember.
https://cdn-api.markitdigital.com/a...access_token=83ff96335c2d45a094df02a206a39ff4
- Forums
- ASX - By Stock
- BYE
- Ann: SM71 F2 & F4 Operations Update and SM69 E2 Production Update
Ann: SM71 F2 & F4 Operations Update and SM69 E2 Production Update, page-68
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BYE (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.25M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.3¢ | $109.5K | 2.052M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 369618 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 45218 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 369618 | 0.053 |
1 | 248412 | 0.052 |
1 | 300000 | 0.051 |
2 | 150000 | 0.050 |
1 | 200000 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 45218 | 1 |
0.056 | 131880 | 2 |
0.057 | 8000 | 1 |
0.058 | 206000 | 2 |
0.059 | 70611 | 2 |
Last trade - 14.37pm 15/07/2024 (20 minute delay) ? |
Featured News
BYE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online